Manoj Pandey – författare

This book comprehensively explores the latest advancements in multiomics strategies for diagnosing gallbladder cancer. The initial section delves into the genetic mutations and molecular pathways critical for the onset and progression of gallbladder cancer. Through targeted gene sequencing and genomic profiling, it identifies both somatic and rare germline mutations, pinpointing driver genes and predisposing mutations. The subsequent section examines the proteins and molecular pathways altered in gallbladder cancer. It uncovers dysregulated proteins, identifies tumor biomarkers, and evaluates circulating markers for early detection. The book further investigates the impact of infections like Salmonella enterica of the serotype Paratyphi A on gallbladder tissue, revealing genotoxic effects and potential biomarkers. It also explores the correlation between the gallbladder microbiome, physiological state, and biliary metabolic profile. Toward the end, the book introduces cutting-edge techniques like machine learning-based CT imaging for survival prediction and examines the role of epigenetic pathways and noncoding RNAs in gallbladder cancer. This section also discusses the potential of targeting mTOR pathways and the significance of inflammatory and immune markers, offering a glimpse into the future of gallbladder cancer diagnosis and treatment. This book is a valuable resource for oncologists and researchers working in the fields of oncology, genomics, proteomics, metabolomics, bioinformatics, molecular biology, and translational medicine.

This book comprehensively explores the latest advancements in multiomics strategies for diagnosing gallbladder cancer. The initial section delves into the genetic mutations and molecular pathways critical for the onset and progression of gallbladder cancer. Through targeted gene sequencing and genomic profiling, it identifies both somatic and rare germline mutations, pinpointing driver genes and predisposing mutations. The subsequent section examines the proteins and molecular pathways altered in gallbladder cancer. It uncovers dysregulated proteins, identifies tumor biomarkers, and evaluates circulating markers for early detection. The book further investigates the impact of infections like Salmonella enterica of the serotype Paratyphi A on gallbladder tissue, revealing genotoxic effects and potential biomarkers. It also explores the correlation between the gallbladder microbiome, physiological state, and biliary metabolic profile. Toward the end, the book introduces cutting-edge techniques like machine learning-based CT imaging for survival prediction and examines the role of epigenetic pathways and noncoding RNAs in gallbladder cancer. This section also discusses the potential of targeting mTOR pathways and the significance of inflammatory and immune markers, offering a glimpse into the future of gallbladder cancer diagnosis and treatment. This book is a valuable resource for oncologists and researchers working in the fields of oncology, genomics, proteomics, metabolomics, bioinformatics, molecular biology, and translational medicine.

The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy.

The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly.

The book is relevant for the clinical researcher, surgeon, scientist and academician.

The book aims to converge the perspectives of authors, editors, and reviewers to discuss modern scientific publishing practice and emerging concerns in the contemporary world.  Authors, editors, and reviewers form a triage in a publishing ecosystem which is witnessing a huge pressure due to changing evaluation criteria for career progression and grant funding. The major perspective of this book is to put forth the present-day emerging ills of modern publishing system and sensitize the research fraternity - be it young researchers or established scientists towards practicing good science and preserving spirit of scientific discoveries.

The edited book consists of three parts viz, Part I “Authors, Authorship, and Scholarly Dissemination” features ten chapters devoted to describe authorship issues and good publication practice, plagiarism concerns, preprints, open access models, conflicting interests, rise of review papers, writing book reviews, and assessing faculty beyond metrics. Part II “Editors, Editorial Desks, and Issues of Scientific Misconduct” features eight chapters devoted to discuss on issues of editorial misconduct, desk rejections, paper mills, letters to editors, image duplication, emerging ChatGPT in writing/reviewing spaces, citation cartels, and retractions. Finally, Part III “Reviewers and Developing Evaluator’s Eye” features five chapters devoted to discuss peer review as an idea creating model, paying peer reviewers, training reviewers, peer review manipulations, and peer review in age of AI . All chapters in the book are written by expert contributors of the field that provides a systematic approach of understanding various challenges, opportunities, and ethical considerations of scientific publishing ecosystem. Most of the chapters have featured recent cases of scientific misconduct as examples to reflect scale of the problem.  

This book will serve as a reference to research practitioners in understanding assigning authorship on papers, modern-day publishing collaboration, role of editors to serve journals in a holistic manner and ensuring fair peer review mechanisms.